The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing patterns of mTORC1 activation across sarcoma subtypes using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database.
 
Daniel S. Lefler
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Erik Blomain
No Relationships to Disclose
 
Robert G. Maki
Consulting or Advisory Role - Boehringer Ingelheim; Deciphera; Eisai; GlaxoSmithKline; Medtronic; PEEL Therapeutics
Speakers' Bureau - MJH Life Sciences
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); InhibRx (Inst); Regeneron (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Stand up to Cancer
(OPTIONAL) Uncompensated Relationships - Fondazione Enrico Pallazzo
 
Jaime Modiano
Honoraria - ImmunityBio
Consulting or Advisory Role - IDEXX Laboratories
Patents, Royalties, Other Intellectual Property - Anivive Lifesciences; Boston Scientific; Kerafast
 
Andreas Seeber
No Relationships to Disclose
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - AADi; Adaptimmune; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; GlaxoSmithKline; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Cogent Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); NanoCarrier (Inst); Oncternal Therapeutics (Inst); Philogen (Inst); PTC Therapeutics (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; NanoCarrier; SpringWorks Therapeutics
 
Aaron Sarver
No Relationships to Disclose
 
Andrea P. Espejo-Freire
No Relationships to Disclose
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Cardiff Oncology
Consulting or Advisory Role - Cardinal Health; Muerus; TriSalus Life Sciences
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbvie (Inst); FOGPharma (Inst); IgM Biosciences (Inst); Torl Biotherapeutics (Inst)
 
Sosipatros Alexandros Boikos
Consulting or Advisory Role - Caris Life Sciences
 
Galina Lagos
No Relationships to Disclose
 
Vaia Florou
Consulting or Advisory Role - Deciphera; Incyte
 
Margaret von Mehren
Honoraria - Boehringer Ingelheim; Deciphera; Molleculin
Consulting or Advisory Role - deciphera
Research Funding - ASCO (Inst); Deciphera (Inst); IDRx (Inst); Novartis (Inst); Solaris Health (Inst); Sumitomo Pharma Oncology (Inst); Theseus (Inst)
Patents, Royalties, Other Intellectual Property - cell line
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - NCCN
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Jonathan C. Trent
Consulting or Advisory Role - AADi; Agios; Bayer; Blueprint Medicines; Boehringer Ingelheim; C4 Therapeutics; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; Foghorn Therapeutics; SERVIER
 
Atrayee Basu Mallick
Stock and Other Ownership Interests - Alexion Pharmaceuticals (I); BMS (I); Pfizer (I)
Consulting or Advisory Role - Bayer; deciphera; deciphera; Novartis
Research Funding - Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Prelude Therapeutics (Inst); Prelude Therapeutics (Inst); PTC therapeutics (Inst); Pyramid Biosciences (Inst); Rgenix (Inst); The Academic GI Cancer Consortium (Inst); TRACON Pharma (Inst)